Marson, Charles M. et al. published their research in Journal of Medicinal Chemistry in 2013 |CAS: 32462-30-9

The Article related to aminophenylbenzamide pyrimidine imidazolinone thiazoline capped preparation histone deacetylase inhibition, thiazoline capped hdac3 ncor1 inhibitor preparation antitumor activity apoptosis and other aspects.Recommanded Product: H-Phg(4-OH)-OH

On August 8, 2013, Marson, Charles M.; Matthews, Christopher J.; Yiannaki, Elena; Atkinson, Stephen J.; Soden, Peter E.; Shukla, Lena; Lamadema, Nermina; Thomas, N. Shaun B. published an article.Recommanded Product: H-Phg(4-OH)-OH The title of the article was Discovery of Potent, Isoform-Selective Inhibitors of Histone Deacetylase Containing Chiral Heterocyclic Capping Groups and a N-(2-Aminophenyl)benzamide Binding Unit. And the article contained the following:

The synthesis of a novel series of potent chiral inhibitors of histone deacetylase (HDAC) is described that contain a heterocyclic capping group and a N-(2-aminophenyl)benzamide unit that binds in the active site. In vitro assays for the inhibition of HDAC1, HDAC2, HDAC3-NCoR1, and HDAC8 by the N-(2-aminophenyl)benzamide I gave resp. IC50 values of 930, 85, 12, and 4100 nM, exhibiting class I selectivity and potent inhibition of HDAC3-NCoR1. Both imidazolinone and thiazoline rings are shown to be effective replacements for the pyrimidine ring present in many other 2-(aminophenyl)benzamides previously reported, an example of each ring system at 1 μM causing an increase in histone H3K9 acetylation in the human cell lines Jurkat and HeLa and an increase in cell death consistent with induction of apoptosis. Inhibition of the growth of MCF-7, A549, DU145, and HCT116 cell lines by I was observed, with resp. IC50 values of 5.4, 5.8, 6.4, and 2.2 mM. The experimental process involved the reaction of H-Phg(4-OH)-OH(cas: 32462-30-9).Recommanded Product: H-Phg(4-OH)-OH

The Article related to aminophenylbenzamide pyrimidine imidazolinone thiazoline capped preparation histone deacetylase inhibition, thiazoline capped hdac3 ncor1 inhibitor preparation antitumor activity apoptosis and other aspects.Recommanded Product: H-Phg(4-OH)-OH

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Murugesan, Dinakaran et al. published their research in ChemMedChem in 2013 |CAS: 386704-04-7

The Article related to pyrrolone piperidine containing preparation antimalarial structure activity relationship, plasmodium falciparum, antiprotozoal agents, malaria, pyrrolones, structure-activity relationships and other aspects.Related Products of 386704-04-7

Murugesan, Dinakaran; Kaiser, Marcel; White, Karen L.; Norval, Suzanne; Riley, Jennifer; Wyatt, Paul G.; Charman, Susan A.; Read, Kevin D.; Yeates, Clive; Gilbert, Ian H. published an article in 2013, the title of the article was Structure-Activity Relationship Studies of Pyrrolone Antimalarial Agents.Related Products of 386704-04-7 And the article contains the following content:

Previously reported pyrrolones, such as TDR32570 (I), exhibited potential as antimalarial agents; however, while these compounds have potent antimalarial activity, they suffer from poor aqueous solubility and metabolic instability. Here, further structure-activity relationship studies are described that aimed to solve the developability issues associated with this series of compounds In particular, further modifications to the lead pyrrolone, involving replacement of a Ph ring with a piperidine and removal of a potentially metabolically labile ester by a scaffold hop, gave rise to derivatives with improved in vitro antimalarial activities against Plasmodium falciparum K1, a chloroquine- and pyrimethamine-resistant parasite strain, with some derivatives exhibiting good selectivity for parasite over mammalian (L6) cells. Three representative compounds were selected for evaluation in a rodent model of malaria infection, and the best compound showed improved ability to decrease parasitemia and a slight increase in survival. The experimental process involved the reaction of (6-(Trifluoromethyl)pyridin-3-yl)methanol(cas: 386704-04-7).Related Products of 386704-04-7

The Article related to pyrrolone piperidine containing preparation antimalarial structure activity relationship, plasmodium falciparum, antiprotozoal agents, malaria, pyrrolones, structure-activity relationships and other aspects.Related Products of 386704-04-7

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Jo, Hwi Yul et al. published their research in Journal of Organic Chemistry in 2021 |CAS: 32462-30-9

The Article related to azidoethanoic acid ruthenium catalyzed decarboxylation condensation, hexahydrotriazine bismethylidenemethanediamine preparation, benzylmethylidene amine preparation, quinazoline preparation and other aspects.Safety of H-Phg(4-OH)-OH

On December 3, 2021, Jo, Hwi Yul; Lee, Jeong Min; Pietrasiak, Ewa; Lee, Eunsung; Rhee, Young Ho; Park, Jaiwook published an article.Safety of H-Phg(4-OH)-OH The title of the article was Generation of N-H imines from α-Azidocarboxylic Acids through Ru-catalyzed Decarboxylation. And the article contained the following:

A new method for the synthesis of N-H imines from α-azidocarboxylic acids was developed, which proceeded through decarboxylative C-C bond cleavage catalyzed by a com. diruthenium complex ([CpRu(CO)2]2) under visible light irradiation at room temperature within several minutes. The reactive products undergo condensation forming cyclic trimers (2,4,6-trialkylhexahydro-1,3,5-triazines) or linear N,N’-bis(arylmethylidene)arylmethanediamines in quant. yields. Alternatively, the N-H imines was trapped with benzylamine and 2-(aminomethyl)aniline providing stable N-benzylimines and tetrahydroquinazolines, resp. Subsequent oxidation of tetrahydroquinazolines produced quinazolines. The experimental process involved the reaction of H-Phg(4-OH)-OH(cas: 32462-30-9).Safety of H-Phg(4-OH)-OH

The Article related to azidoethanoic acid ruthenium catalyzed decarboxylation condensation, hexahydrotriazine bismethylidenemethanediamine preparation, benzylmethylidene amine preparation, quinazoline preparation and other aspects.Safety of H-Phg(4-OH)-OH

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Dias, Patricia et al. published their research in Nutrients in 2022 |CAS: 621-37-4

The Article related to blood pressure flavonoid metabolite 3hydroxyphenylacetic acid, 3-hydroxyphenylacetic acid, artery, blood pressure, coronary, flavonoids, gut microbiota, metabolite, pig, rat, vasorelaxation and other aspects.Category: alcohols-buliding-blocks

Dias, Patricia; Pourova, Jana; Voprsalova, Marie; Nejmanova, Iveta; Mladenka, Premysl published an article in 2022, the title of the article was 3-Hydroxyphenylacetic Acid: A Blood Pressure-Reducing Flavonoid Metabolite.Category: alcohols-buliding-blocks And the article contains the following content:

Regular intake of polyphenol-rich food has been associated with a wide variety of beneficial health effects, including the prevention of cardiovascular diseases. However, the parent flavonoids have mostly low bioavailability and, hence, their metabolites have been hypothesized to be bioactive. One of these metabolites, 3-hydroxyphenylacetic acid (3-HPAA), formed by the gut microbiota, was previously reported to exert vasorelaxant effects ex vivo. The aim of this study was to shed more light on this effect in vivo, and to elucidate the mechanism of action. 3-HPAA gave rise to a dose-dependent decrease in arterial blood pressure when administered i.v. both as a bolus and infusion to spontaneously hypertensive rats. In contrast, no significant changes in heart rate were observed In ex vivo experiments, where porcine hearts from a slaughterhouse were used to decrease the need for laboratory animals, 3-HPAA relaxed precontracted porcine coronary artery segments via a mechanism partially dependent on endothelium integrity. This relaxation was significantly impaired after endothelial nitric oxide synthase inhibition. In contrast, the blockade of SKCa or IKCa channels, or muscarinic receptors, did not affect 3-HPAA relaxation. Similarly, no effects of 3-HPAA on cyclooxygenase nor L-type calcium channels were observed Thus, 3-HPAA decreases blood pressure in vivo via vessel relaxation, and this mechanism might be based on the release of nitric oxide by the endothelial layer. The experimental process involved the reaction of 3-Hydroxyphenylacetic acid(cas: 621-37-4).Category: alcohols-buliding-blocks

The Article related to blood pressure flavonoid metabolite 3hydroxyphenylacetic acid, 3-hydroxyphenylacetic acid, artery, blood pressure, coronary, flavonoids, gut microbiota, metabolite, pig, rat, vasorelaxation and other aspects.Category: alcohols-buliding-blocks

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Fagbohun, Oladapo F. et al. published their research in Journal of Pharmacy and Pharmacology in 2020 |CAS: 96-76-4

The Article related to metabolome modulatory effect kigelia africana oxidative stress hyperlipidemic biomarker, kigelia africana , diabetes mellitus , gc-tof-ms, antioxidant enzymes, avidin-biotin immunoperoxidase and other aspects.Synthetic Route of 96-76-4

On December 31, 2020, Fagbohun, Oladapo F.; Olawoye, Babatunde; Ademakinwa, Adedeji N.; Jolayemi, Kehinde A.; Msagati, Titus A. M. published an article.Synthetic Route of 96-76-4 The title of the article was Metabolome modulatory effects of Kigelia africana (Lam.) Benth. fruit extracts on oxidative stress, hyperlipidaemic biomarkers in STZ-induced diabetic rats and antidiabetic effects in 3T3 L1 adipocytes. And the article contained the following:

The management of diabetes is considered a global problem, and a cure is yet to be discovered. This study investigated the modulatory effect of Kigelia africana fruit on oxidative stress and hyperlipidemic biomarkers in STZ-induced diabetic rats, profiled phytoconstituents using GC-TOF-MS and evaluated antidiabetic effects on 3T3 L1 adipocytes. Thirty male Wistar rats (120-150 g) were divided into six groups (n = 5). Diabetes was induced by a single i.p. injection of STZ (60 mg/kg) and treated with 100, 200 and 400 of hexane fraction of KA for 28 days. Immunohistochem. evaluation was carried out using avidin-biotin immunoperoxidase (ABI) method. Catalase and SOD activities as well as the levels of total protein, albumin, bilirubin, triglyceride, cholesterol, and high-d. lipoprotein were measured. The expressions of oxidative stress and hyperlipidemic biomarkers alongside fasting blood glucose concentrations were remarkedly decreased in KA-treated diabetic rats. Moreover, there was a significant increase in endocrine cell distribution, area covered with increase in β-cell mass, composition and morphol. of KA-treated animals. Addnl., there was constant up-regulation in 3T3 L1 adipocytes due to the presence of phytoconstituents. Kigelia africana fruit can act as a modulatory agent due to its ameliorative effects against oxidative stress. The experimental process involved the reaction of 2,4-Di-tert-butylphenol(cas: 96-76-4).Synthetic Route of 96-76-4

The Article related to metabolome modulatory effect kigelia africana oxidative stress hyperlipidemic biomarker, kigelia africana , diabetes mellitus , gc-tof-ms, antioxidant enzymes, avidin-biotin immunoperoxidase and other aspects.Synthetic Route of 96-76-4

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Chandra, Pallavi et al. published their research in mBio in 2020 |CAS: 32462-30-9

The Article related to fatty acid oxidation inhibition macrophage mitochondria tuberculosis, mycobacterium tuberculosis , nadph oxidase, fatty acid oxidation, innate immunity, macrophages, mitochondrial metabolism and other aspects.Name: H-Phg(4-OH)-OH

Chandra, Pallavi; He, Li; Zimmerman, Matthew; Yang, Guozhe; Koster, Stefan; Ouimet, Mireille; Wang, Han; Moore, Kathyrn J.; Dartois, Veronique; Schilling, Joel D.; Philips, Jennifer A. published an article in 2020, the title of the article was Inhibition of fatty acid oxidation promotes macrophage control of Mycobacterium tuberculosis.Name: H-Phg(4-OH)-OH And the article contains the following content:

Macrophage activation involves metabolic reprogramming to support antimicrobial cellular functions. How these metabolic shifts influence the outcome of infection by intracellular pathogens remains incompletely understood. Mycobacterium tuberculosis (Mtb) modulates host metabolic pathways and utilizes host nutrients, including cholesterol and fatty acids, to survive within macrophages. We found that intracellular growth of Mtb depends on host fatty acid catabolism: when host fatty acid β-oxidation (FAO) was blocked chem. with trimetazidine, a compound in clin. use, or genetically by deletion of the mitochondrial fatty acid transporter carnitine palmitoyltransferase 2 (CPT2), Mtb failed to grow in macrophages, and its growth was attenuated in mice. Mechanistic studies support a model in which inhibition of FAO generates mitochondrial reactive oxygen species, which enhance macrophage NADPH oxidase and xenophagy activity to better control Mtb infection. Thus, FAO inhibition promotes key antimicrobial functions of macrophages and overcomes immune evasion mechanisms of Mtb. The experimental process involved the reaction of H-Phg(4-OH)-OH(cas: 32462-30-9).Name: H-Phg(4-OH)-OH

The Article related to fatty acid oxidation inhibition macrophage mitochondria tuberculosis, mycobacterium tuberculosis , nadph oxidase, fatty acid oxidation, innate immunity, macrophages, mitochondrial metabolism and other aspects.Name: H-Phg(4-OH)-OH

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Li, Kun-Ping et al. published their research in Molecular Nutrition & Food Research in 2022 |CAS: 473-81-4

The Article related to high fructose diet gut microbiome metabolome immunity obesity, lps-tlr4, chronic inflammation, gut microbiota, innate immune system, integrated multi-omics analysis, α-hydroxyisobutyric acid and other aspects.Synthetic Route of 473-81-4

On April 30, 2022, Li, Kun-Ping; Yuan, Min; Wu, Yong-Lin; Pineda, Miguel; Zhang, Chu-Mei; Chen, Yan-Fen; Chen, Zhi-quan; Rong, Xiang-Lu; Turnbull, Jeremy E.; Guo, Jiao published an article.Synthetic Route of 473-81-4 The title of the article was A High-Fat High-Fructose Diet Dysregulates the Homeostatic Crosstalk Between Gut Microbiome, Metabolome, and Immunity in an Experimental Model of Obesity. And the article contained the following:

Ample evidence supports the prominent role of gut-liver axis in perpetuating pathol. networks of high-fat high-fructose (HFF) diet induced metabolic disorders, however, the mol. mechanisms are still not fully understood. Herein, this study aims to present a holistic delineation and scientific explanation for the crosstalk between the gut and liver, including the potential mediators involved in orchestrating the metabolic and immune systems. An exptl. obesity-associated metaflammation rat model is induced with a HFF diet. An integrative multi-omics anal. is then performed. Following the clues illustrated by the multi-omics discoveries, putative pathways are subsequently validated by RT-qPCR and Western blotting. HFF diet leads to obese phenotypes in rats, as well as histopathol. changes. Integrated omics anal. shows that there exists a strong interdependence among gut microbiota composition, intestinal metabolites, and innate immunity regulation in the liver. Some carboxylic acids may contribute to gut-liver communication. Moreover, activation of the hepatic LPS-TLR4 pathway in obesity is confirmed. HFF-intake disturbs gut flora homeostasis. Crosstalk between gut microbiota and innate immune system mediates hepatic metaflammation in obese rats, associated with LPS-TLR4 signaling pathway activation. Moreover, α-hydroxyisobutyric acid and some other organic acids may play a role as messengers in the liver-gut axis. The experimental process involved the reaction of 2,3-Dihydroxypropanoic acid(cas: 473-81-4).Synthetic Route of 473-81-4

The Article related to high fructose diet gut microbiome metabolome immunity obesity, lps-tlr4, chronic inflammation, gut microbiota, innate immune system, integrated multi-omics analysis, α-hydroxyisobutyric acid and other aspects.Synthetic Route of 473-81-4

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Young, Robert N. et al. published their patent in 1989 |CAS: 42900-89-0

The Article related to quinoline preparation leukotriene antagonist, antiasthmatic quinoline preparation, antiallergic quinoline preparation, antiinflammatory quinoline preparation, antiulcer quinoline preparation and other aspects.Formula: C9H10O2

On May 31, 1989, Young, Robert N.; Zamboni, Robert; Gauthier, Jacques Y.; Belley, Michel L. published a patent.Formula: C9H10O2 The title of the patent was Quinoline diacid derivatives useful as leukotriene antagonists, and their pharmaceutical compositions and use in medicaments. And the patent contained the following:

Title compounds I [R1 = H, halo, alkyl, alkenyl, alkynyl, CF3, SR2, S(O)R2, S(O)2R2, NR3R3, OR3, CO2R3, COR3, C(OH)R3R3, cyano,NO2, N3, (un)substituted Ph, PhCH2, PhCH2CH2, pyridyl; R2 = alkyl, alkenyl, alkynyl, CF3, (un)substituted Ph, PhCH2, PhCH2CH2; R3 = H, R2; R4 = H, halo, NO2, N3, cyano, SR2, NR3R3, OR3, alkyl, COR3; R5 = H, alkyl; Y = CR3:CR3, C:C, CO, NR3CO, CONR3, O, S, NR3, etc.; X1, X2 = complex chains, 1 or both containing C6H4, pyridine, or thiophene nucleus; Q1, Q2 = CO2R3, tetrazole, cyano, CHO, CH2OH, COCH2OH, etc.] are prepared for use as leukotriene antagonists (no data), and thereby as antiasthmatic, antiallergic, antiinflammatory, and cytoprotective agents. Thus, Wittig reaction of Me 2-[3-[2-(methoxycarbonyl)ethylthio]-3-(3-formylphenyl)propyl]benzoate (prepared in 6 steps) with [(7-chloroquinolin-2-yl)methyl]triphenylphosphonium bromide using BuLi in THF, and basic hydrolysis and salification of the product, gave [[[(chloroquinolinyl)ethenyl]phenyl](carboxyethylthio)propyl]benzoic acid di-Na salt II. The experimental process involved the reaction of Isochroman-3-ol(cas: 42900-89-0).Formula: C9H10O2

The Article related to quinoline preparation leukotriene antagonist, antiasthmatic quinoline preparation, antiallergic quinoline preparation, antiinflammatory quinoline preparation, antiulcer quinoline preparation and other aspects.Formula: C9H10O2

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Guo, Bin et al. published their research in Bioorganic & Medicinal Chemistry in 2018 |CAS: 280752-78-5

The Article related to dihydrobenzodioxine propanoic acid preparation gpr40 agonist antidiabetic pharmacokinetic profile, 2,3-dihydrobenzo[b][1,4]dioxine, gpr40 agonist, insulin secretion, type 2 diabetes mellitus and other aspects.Product Details of 280752-78-5

On December 1, 2018, Guo, Bin; Guo, Shimeng; Huang, Jing; Li, Jingya; Li, Jia; Chen, Qian; Zhou, Xianli; Xie, Xin; Yang, Yushe published an article.Product Details of 280752-78-5 The title of the article was Design and optimization of 2,3-dihydrobenzo[b][1,4]dioxine propanoic acids as novel GPR40 agonists with improved pharmacokinetic and safety profiles. And the article contained the following:

GPR40 has become a new potential therapeutic target for the treatment of diabetes due to its role in mediating the enhancement of glucose-stimulated insulin secretion in pancreatic β cells with a low risk of hypoglycemia. As an effort to extend the chem. space and identify structurally distinct GPR40 agonists with improved liver safety, a novel series of fused-ring Ph propanoic acid analogs were designed. Comprehensive structure-activity relationship studies around novel scaffolds were conducted and led to several analogs exhibited potent GPR40 agonistic activities and high selectivity against other fatty acid receptors. Further evaluation of pharmacokinetic (PK) profiles and in vivo efficacy identified compound I with excellent PK properties and significant glucose-lowering efficacy during an oral glucose tolerance test. In addition, compound I displayed lower hepatobiliary transporter inhibition and favorable druggability. All results indicate that compound I is a promising candidate for further development. The experimental process involved the reaction of (6-Bromo-2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanol(cas: 280752-78-5).Product Details of 280752-78-5

The Article related to dihydrobenzodioxine propanoic acid preparation gpr40 agonist antidiabetic pharmacokinetic profile, 2,3-dihydrobenzo[b][1,4]dioxine, gpr40 agonist, insulin secretion, type 2 diabetes mellitus and other aspects.Product Details of 280752-78-5

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts

Bollinger, Katrina A. et al. published their research in ACS Medicinal Chemistry Letters in 2017 |CAS: 386704-04-7

The Article related to mglu2 central nervous system penetration picolinamide pharmacokinetics, cns penetration, negative allosteric modulator (nam), vu6001966, depression, metabotropic glutamate receptor 2 (mglu2) and other aspects.Related Products of 386704-04-7

On September 14, 2017, Bollinger, Katrina A.; Felts, Andrew S.; Brassard, Christopher J.; Engers, Julie L.; Rodriguez, Alice L.; Weiner, Rebecca L.; Cho, Hyekyung P.; Chang, Sichen; Bubser, Michael; Jones, Carrie K.; Blobaum, Anna L.; Niswender, Colleen M.; Conn, P. Jeffrey; Emmitte, Kyle A.; Lindsley, Craig W. published an article.Related Products of 386704-04-7 The title of the article was Design and Synthesis of mGlu2 NAMs with Improved Potency and CNS Penetration Based on a Truncated Picolinamide Core. And the article contained the following:

Herein, the authors detail the optimization of the mGlu2 neg. allosteric modulator (NAM), 4-(4-fluorophenyl)-5-((1-methyl-1H-pyrazol-3-yl)methoxy)picolinamide (VU6001192), by a reductionist approach to afford a novel, simplified mGlu2 NAM scaffold. This new chemotype not only affords potent and selective mGlu2 inhibition, as exemplified by VU6001966 (mGlu2 IC50 = 78 nM, mGlu3 IC50 > 30 μM), but also excellent central nervous system (CNS) penetration (Kp = 1.9, Kp,uu = 0.78), a feature devoid in all previously disclosed mGlu2 NAMs (Kps ≈ 0.3, Kp,uus ≈ 0.1). Moreover, this series, based on overall properties, represents an exciting lead series for potential mGlu2 PET tracer development. The experimental process involved the reaction of (6-(Trifluoromethyl)pyridin-3-yl)methanol(cas: 386704-04-7).Related Products of 386704-04-7

The Article related to mglu2 central nervous system penetration picolinamide pharmacokinetics, cns penetration, negative allosteric modulator (nam), vu6001966, depression, metabotropic glutamate receptor 2 (mglu2) and other aspects.Related Products of 386704-04-7

Referemce:
Alcohol – Wikipedia,
Alcohols – Chemistry LibreTexts